vs

Side-by-side financial comparison of INVO Fertility, Inc. (IVF) and Laser Photonics Corp (LASE). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $919.3K, roughly 1.9× Laser Photonics Corp). INVO Fertility, Inc. runs the higher net margin — -150.5% vs -506.4%, a 355.9% gap on every dollar of revenue. On growth, Laser Photonics Corp posted the faster year-over-year revenue change (28.3% vs 22.6%). Over the past eight quarters, INVO Fertility, Inc.'s revenue compounded faster (12.8% CAGR vs -3.9%).

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.

IVF vs LASE — Head-to-Head

Bigger by revenue
IVF
IVF
1.9× larger
IVF
$1.8M
$919.3K
LASE
Growing faster (revenue YoY)
LASE
LASE
+5.7% gap
LASE
28.3%
22.6%
IVF
Higher net margin
IVF
IVF
355.9% more per $
IVF
-150.5%
-506.4%
LASE
Faster 2-yr revenue CAGR
IVF
IVF
Annualised
IVF
12.8%
-3.9%
LASE

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
IVF
IVF
LASE
LASE
Revenue
$1.8M
$919.3K
Net Profit
$-2.6M
$-4.7M
Gross Margin
-20.1%
Operating Margin
-93.1%
-350.0%
Net Margin
-150.5%
-506.4%
Revenue YoY
22.6%
28.3%
Net Profit YoY
-62.2%
-186.5%
EPS (diluted)
$-0.77
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVF
IVF
LASE
LASE
Q3 25
$1.8M
$919.3K
Q2 25
$1.9M
$2.6M
Q1 25
$1.6M
$2.3M
Q4 24
$1.7M
$1.3M
Q3 24
$1.4M
$716.7K
Q2 24
$1.8M
$623.4K
Q1 24
$1.6M
$743.0K
Q4 23
$1.4M
$994.6K
Net Profit
IVF
IVF
LASE
LASE
Q3 25
$-2.6M
$-4.7M
Q2 25
$-5.3M
$-1.8M
Q1 25
$-17.4M
$-1.7M
Q4 24
$-3.6M
$586.4K
Q3 24
$-1.6M
$-1.6M
Q2 24
$-2.2M
$-934.3K
Q1 24
$-1.6M
$-545.7K
Q4 23
$-2.0M
$-486.6K
Gross Margin
IVF
IVF
LASE
LASE
Q3 25
-20.1%
Q2 25
53.5%
Q1 25
35.2%
49.8%
Q4 24
41.4%
13.3%
Q3 24
31.0%
85.0%
Q2 24
53.1%
50.6%
Q1 24
45.3%
51.9%
Q4 23
33.0%
84.5%
Operating Margin
IVF
IVF
LASE
LASE
Q3 25
-93.1%
-350.0%
Q2 25
-160.4%
-37.0%
Q1 25
-1042.1%
-68.7%
Q4 24
-202.0%
-255.1%
Q3 24
-90.7%
-238.0%
Q2 24
-100.9%
-149.4%
Q1 24
-95.7%
-73.8%
Q4 23
-109.2%
-88.4%
Net Margin
IVF
IVF
LASE
LASE
Q3 25
-150.5%
-506.4%
Q2 25
-283.6%
-68.3%
Q1 25
-1060.1%
-73.4%
Q4 24
-211.3%
45.7%
Q3 24
-113.8%
-226.8%
Q2 24
-122.2%
-149.9%
Q1 24
-101.3%
-73.4%
Q4 23
-144.4%
-48.9%
EPS (diluted)
IVF
IVF
LASE
LASE
Q3 25
$-0.77
$-0.27
Q2 25
$-13.30
$-0.12
Q1 25
$-12.53
$-0.12
Q4 24
$14.86
$0.06
Q3 24
$-15.11
$-0.13
Q2 24
$-22.39
$-0.09
Q1 24
$-7.55
$-0.06
Q4 23
$-59.51
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVF
IVF
LASE
LASE
Cash + ST InvestmentsLiquidity on hand
$3.6M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$5.8M
$4.1M
Total Assets
$18.8M
$17.5M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVF
IVF
LASE
LASE
Q3 25
$3.6M
Q2 25
$78.5K
Q1 25
$179.1K
Q4 24
$533.9K
Q3 24
$2.1M
Q2 24
$2.7M
Q1 24
$5.2M
Q4 23
$6.2M
Total Debt
IVF
IVF
LASE
LASE
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Q4 23
Stockholders' Equity
IVF
IVF
LASE
LASE
Q3 25
$5.8M
$4.1M
Q2 25
$2.6M
$4.3M
Q1 25
$3.3M
$6.8M
Q4 24
$12.7M
$10.2M
Q3 24
$-23.3K
$9.7M
Q2 24
$1.4M
$10.3M
Q1 24
$10.2K
$12.4M
Q4 23
$892.8K
$13.9M
Total Assets
IVF
IVF
LASE
LASE
Q3 25
$18.8M
$17.5M
Q2 25
$19.3M
$14.9M
Q1 25
$31.7M
$16.0M
Q4 24
$46.4M
$17.2M
Q3 24
$17.0M
$10.6M
Q2 24
$17.8M
$11.1M
Q1 24
$17.3M
$13.6M
Q4 23
$18.5M
$15.1M
Debt / Equity
IVF
IVF
LASE
LASE
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVF
IVF
LASE
LASE
Operating Cash FlowLast quarter
$-1.8M
$763.1K
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-101.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVF
IVF
LASE
LASE
Q3 25
$-1.8M
$763.1K
Q2 25
$-1.7M
$-1.0M
Q1 25
$-3.5M
$-1.2M
Q4 24
$-617.4K
$-6.5M
Q3 24
$-640.8K
$632.7K
Q2 24
$-1.5M
$-2.4M
Q1 24
$-260.6K
$-866.3K
Q4 23
$-714.9K
$-2.0M
Free Cash Flow
IVF
IVF
LASE
LASE
Q3 25
$-1.8M
Q2 25
$-1.7M
Q1 25
$-3.6M
Q4 24
$-696.3K
Q3 24
$589.6K
Q2 24
$-1.5M
$-2.4M
Q1 24
$-310.3K
$-1.0M
Q4 23
FCF Margin
IVF
IVF
LASE
LASE
Q3 25
-101.6%
Q2 25
-92.6%
Q1 25
-216.9%
Q4 24
-40.6%
Q3 24
82.3%
Q2 24
-82.3%
-388.0%
Q1 24
-19.7%
-136.9%
Q4 23
Capex Intensity
IVF
IVF
LASE
LASE
Q3 25
0.5%
Q2 25
0.5%
Q1 25
0.9%
Q4 24
4.6%
Q3 24
0.0%
6.0%
Q2 24
3.0%
5.1%
Q1 24
3.2%
20.3%
Q4 23
Cash Conversion
IVF
IVF
LASE
LASE
Q3 25
Q2 25
Q1 25
Q4 24
-11.11×
Q3 24
Q2 24
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons